902 related articles for article (PubMed ID: 29626238)
41. An investigation of machine learning methods in delta-radiomics feature analysis.
Chang Y; Lafata K; Sun W; Wang C; Chang Z; Kirkpatrick JP; Yin FF
PLoS One; 2019; 14(12):e0226348. PubMed ID: 31834910
[TBL] [Abstract][Full Text] [Related]
42. Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation.
Bhattacharjee R; Gupta M; Singh T; Sharma S; Khanna G; Parvaze SP; Patir R; Vaishya S; Ahlawat S; Singh A; Gupta RK
Neuroradiology; 2022 Sep; 64(9):1801-1818. PubMed ID: 35435463
[TBL] [Abstract][Full Text] [Related]
43. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
[TBL] [Abstract][Full Text] [Related]
44. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
Wang P; Shi YH; Li JY; Zhang CZ
World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic performance of DWI for differentiating primary central nervous system lymphoma from glioblastoma: a systematic review and meta-analysis.
Lu X; Xu W; Wei Y; Li T; Gao L; Fu X; Yao Y; Wang L
Neurol Sci; 2019 May; 40(5):947-956. PubMed ID: 30706241
[TBL] [Abstract][Full Text] [Related]
46. Differences between primary central nervous system lymphoma and glioblastoma: topographic analysis using voxel-based morphometry.
Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Momosaka D; Hata N; Akagi Y; Suzuki SO; Iwaki T; Iihara K; Honda H
Clin Radiol; 2019 Oct; 74(10):816.e1-816.e8. PubMed ID: 31400805
[TBL] [Abstract][Full Text] [Related]
47. Comparison of machine learning classifiers for differentiation of grade 1 from higher gradings in meningioma: A multicenter radiomics study.
Hamerla G; Meyer HJ; Schob S; Ginat DT; Altman A; Lim T; Gihr GA; Horvath-Rizea D; Hoffmann KT; Surov A
Magn Reson Imaging; 2019 Nov; 63():244-249. PubMed ID: 31425811
[TBL] [Abstract][Full Text] [Related]
48. Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imaging.
Park YW; Oh J; You SC; Han K; Ahn SS; Choi YS; Chang JH; Kim SH; Lee SK
Eur Radiol; 2019 Aug; 29(8):4068-4076. PubMed ID: 30443758
[TBL] [Abstract][Full Text] [Related]
49. Comparison between Glioblastoma and Primary Central Nervous System Lymphoma Using MR Image-based Texture Analysis.
Kunimatsu A; Kunimatsu N; Kamiya K; Watadani T; Mori H; Abe O
Magn Reson Med Sci; 2018 Jan; 17(1):50-57. PubMed ID: 28638001
[TBL] [Abstract][Full Text] [Related]
50. Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma.
MacIver CL; Busaidi AA; Ganeshan B; Maynard JA; Wastling S; Hyare H; Brandner S; Markus JE; Lewis MA; Groves AM; Cwynarski K; Thust SC
J Pers Med; 2021 Aug; 11(9):. PubMed ID: 34575653
[TBL] [Abstract][Full Text] [Related]
51. Classification of glioblastoma versus primary central nervous system lymphoma using convolutional neural networks.
McAvoy M; Prieto PC; Kaczmarzyk JR; Fernández IS; McNulty J; Smith T; Yu KH; Gormley WB; Arnaout O
Sci Rep; 2021 Jul; 11(1):15219. PubMed ID: 34312463
[TBL] [Abstract][Full Text] [Related]
52. Achieving imaging and computational reproducibility on multiparametric MRI radiomics features in brain tumor diagnosis: phantom and clinical validation.
Cheong EN; Park JE; Park SY; Jung SC; Kim HS
Eur Radiol; 2024 Mar; 34(3):2008-2023. PubMed ID: 37665391
[TBL] [Abstract][Full Text] [Related]
53. [Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma].
Li MG; Chen ZY; Liu G; Xiao HF; Chen XJ; Lou X; Ma L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):146-150. PubMed ID: 29724302
[TBL] [Abstract][Full Text] [Related]
54. Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?
Malikova H; Koubska E; Weichet J; Klener J; Rulseh A; Liscak R; Vojtech Z
Cancer Imaging; 2016 Nov; 16(1):40. PubMed ID: 27894359
[TBL] [Abstract][Full Text] [Related]
55. Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.
Lee B; Park JE; Bjørnerud A; Kim JH; Lee JY; Kim HS
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1415-1422. PubMed ID: 30026384
[TBL] [Abstract][Full Text] [Related]
56. Differentiating glioblastoma from primary central nervous system lymphoma of atypical manifestation using multiparametric magnetic resonance imaging: A comparative study.
Feng A; Li L; Huang T; Li S; He N; Huang L; Zeng M; Lyu J
Heliyon; 2023 Apr; 9(4):e15150. PubMed ID: 37095995
[TBL] [Abstract][Full Text] [Related]
57. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
58. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
[TBL] [Abstract][Full Text] [Related]
59. Differentiation of Primary Central Nervous System Lymphoma From Glioblastoma: Quantitative Analysis Using Arterial Spin Labeling and Diffusion Tensor Imaging.
Abdel Razek AAK; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
World Neurosurg; 2019 Mar; 123():e303-e309. PubMed ID: 30502475
[TBL] [Abstract][Full Text] [Related]
60. Current status and quality of radiomics studies in lymphoma: a systematic review.
Wang H; Zhou Y; Li L; Hou W; Ma X; Tian R
Eur Radiol; 2020 Nov; 30(11):6228-6240. PubMed ID: 32472274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
